Make investment in life sciences a government priority, says FranceBiotech
This article was originally published in Scrip
Executive Summary
France Biotech, the French life sciences association, says government funding made available to counter the financial crisis, should be used to expand the national research agency and increase investment in innovation in areas including stem cell research and therapeutic vaccine development.